News from the life sciences community north of Boston
January 2022
The 40th Annual J.P. Morgan Health Care Conference is underway this week - virtually - with many research collaborations announced in the first few days.

For conference highlights, check out FiercePharma's daily coverage.
Updates from Massachusetts companies include Intellia's plans to include cardiomyopathy patients in an existing early-stage study of its gene-editing therapy NTLA-2001; expected data release for Editas Medicine's vision-loss therapy this year; and Ironwood Pharmaceutical's expected growth of gastrointestinal drug Linzess, along with opportunities to introduce more GI medicines to its pipeline.
Additionally, Boston Business Journal reports that Biogen defended its Alzheimer's drug, Aduhelm, at the conference, and discussed the company's drug pipeline.
With remarkable healthcare and life sciences advances underway, workforce development continues to be an important challenge and opportunity for the Commonwealth.
Among the thought leaders addressing this issue is Gloucester Marine Genomics Institute (GMGI). A leading member of the science community in MetroNorth, GMGI is working to provide hands-on science education opportunities to prepare the next generation of biotech professionals.
Photo credit: Paul Bilodeau, Gloucester Daily Times
GMGI recently hosted U.S. Rep. Seth Moulton, Senate Minority Leader Bruce Tarr, state Rep. Ann-Margaret Ferrante, and Gloucester Mayor Greg Verga for a tour of its lab and Biotechnology Academy, both in Gloucester. The group was hosted by GMGI executive director Christine Bolzan, science director Andrea Bodnar, and board member Bill Kane.
An article in Gloucester Daily Times detailed the visit and how $1 million from the state Legislature's pandemic relief bill will support life sciences growth in Gloucester. GMGI offers a workforce training program for young people with high school degrees or equivalent to start a career in biotechnology.
New England Biolabs (NEB), a leader in the discovery and development of molecular biology reagents, recently occupied a new research and development facility at 43/44 Dunham Ridge. The company's 33,000-square-foot facility includes 22,000 SF of lab space and 11,000 SF of office space, including a staff lounge, conference rooms, assembly room, and lobby area. Wise Construction was selected by NEB to manage the lab and office fit out of a new shell and core building developed by Cummings. See additional photos and read more about the project on the Wise Construction blog.
Thrive Bioscience is expanding from its Wakefield location to an office and R&D suite at 100 Cummings Center, Beverly plus a lab space at North Shore InnoVentures. Thrive Bioscience provides instruments and software designed to increase the speed, quality, and cost-effectiveness of drug discovery and basic research while supporting the delivery of new therapies by improving the cell, stem cell, and tissue culture process. Thomas Forest Farb-Horch is CEO, co-founder, and board member.
Ian Chan, CEO of Abpro Corporation (68 Cummings Park, Woburn) was recently interviewed by Boston Business Journal. The company recently expanded its focus on antibody therapies to include experimental drug candidates to fight Covid-19.
"We wanted something that would be future-proofed against mutations yet to come, so that it could withstand the test of time."
Ian Chan
Executive Chairman and Co-founder, Abpro
Just 10 months out of stealth mode, SalioGen Therapeuics (8 Cabot Road, Woburn) has raised another $115 million of Series B funding. Fierce Biotech covered the funding news and SalioGen's work to develop genetic medicines to treat eye and liver diseases. Ray Tabibiazar is SalioGen's CEO and chairman.
Build-to-Suit Lab Opportunities in Woburn - 6,600 and 11,200 SF
Two proposed lab conversions at Cummings Landmark TradeCenter campus present an opportunity to join the vibrant and fast-growing life sciences community in Woburn.
100 TradeCenter - 6,640 SF
Suites 600 & 700
100 TradeCenter - 11,193 SF
Suite 780
The growing life sciences community at TradeCenter includes:
MassBio Regional Mixer: Woburn. Join MassBio for its first regional mixer of 2022 at Lord Hobo Brewery in Woburn. Appetizers and drinks will be served. All attendees at the event are required to be fully vaccinated, and masks will be required in all common areas of the event space, except while eating or drinking. Thursday, February 17 at 5:00 PM. Register.
Biosciences Forum Virtual Networking, presented by North Shore Technology Council. Join NSTC board members and others in the North Shore region who share a passion for, or do business with, the biosciences industry. Thursday, February 24, 5:00 - 5:45 PM. This is an informal Zoom event with no agenda except to share a virtual after-work beverage and experience a new way of networking. Register.
The Boston Globe reports that Coronavirus levels in Boston-area waste water are declining after a dramatic spike. This hopeful trend may indicate that the wave of COVID-19 cases from the Omicron variant is about to crest.

The testing is conducted by Cambridge-based Biobot Analytics.
Have news to share? Please let us know! We are interested in company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at to share your news for upcoming newsletters. We look forward to hearing from you.
Keep up with news from the Cummings community by following us on LinkedInFacebookTwitter, and Instagram.